Medicine & Life Sciences
Acinetobacter
9%
Alcaligenes faecalis
26%
Amikacin
9%
Anaerobic Bacteria
47%
Anti-Bacterial Agents
45%
Anti-Infective Agents
9%
Bacteria
28%
Cefepime
20%
Cefotaxime
9%
Cefotetan
10%
Ceftriaxone
54%
Chloramphenicol
14%
Ciprofloxacin
16%
Clostridium perfringens
17%
Communicable Diseases
12%
Developing Countries
14%
Diarrhea
12%
DNA
10%
Enterobacter aerogenes
45%
Escherichia coli
38%
Gastrointestinal Tract
33%
Global Health
9%
Gram-Negative Bacteria
45%
Gram-Positive Bacteria
10%
Health Care Costs
8%
Indonesia
100%
Infections
24%
Klebsiella oxytoca
34%
Klebsiella pneumoniae
24%
Leptospira
53%
Leptospirosis
16%
Levofloxacin
18%
Limit of Detection
13%
Medicine
62%
Metronidazole
14%
Microbial Drug Resistance
9%
Microbiology
98%
Morbidity
10%
Mortality
12%
Pneumonia
25%
Real-Time Polymerase Chain Reaction
30%
Salmonella paratyphi A
15%
Salmonella typhi
62%
Serratia marcescens
12%
Shigella flexneri
13%
Streptococcus pneumoniae
9%
Sulbenicillin
13%
Tazobactam
40%
Ticarcillin
11%
Urine
27%
Agriculture & Biology
Acinetobacter calcoaceticus var. anitratus
13%
Alcaligenes faecalis
22%
amikacin
9%
anti-infective agents
29%
antibiotics
5%
blood
22%
blood flow
7%
cefotaxime
9%
ceftriaxone
10%
ciprofloxacin
17%
Enterobacter aerogenes
40%
Escherichia coli
19%
gentamicin
8%
Gram-negative bacteria
37%
Indonesia
7%
Klebsiella oxytoca
32%
Klebsiella pneumoniae subsp. pneumoniae
44%
levofloxacin
21%
medicine
6%
microbiology
8%
pneumonia
8%
Pseudomonas aeruginosa
7%
Salmonella Typhi
49%
therapeutics
6%